PIGNATARO, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 180
AS - Asia 83
Totale 753
Nazione #
US - Stati Uniti d'America 490
IT - Italia 93
CN - Cina 54
SE - Svezia 52
SG - Singapore 17
GB - Regno Unito 9
IN - India 7
DE - Germania 6
FR - Francia 6
IE - Irlanda 5
BE - Belgio 2
FI - Finlandia 2
VN - Vietnam 2
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IR - Iran 1
LT - Lituania 1
NL - Olanda 1
TH - Thailandia 1
TR - Turchia 1
Totale 753
Città #
Chandler 72
Bari 66
Fairfield 57
Ashburn 48
Nyköping 40
Houston 37
Woodbridge 30
Seattle 29
Wilmington 20
Ann Arbor 19
New York 17
Cambridge 15
Singapore 13
Lawrence 9
Roxbury 9
San Diego 8
Inglewood 7
Pune 7
Des Moines 6
Guangzhou 6
Nanjing 6
Dublin 5
Dearborn 4
Turin 4
Beijing 3
Grumo Appula 3
Jiaxing 3
Los Angeles 3
Trani 3
Wuhan 3
Boardman 2
Bologna 2
Boydton 2
Brooklyn 2
Brussels 2
Changsha 2
Dong Ket 2
London 2
Munich 2
Nanchang 2
Paris 2
Princeton 2
San Mateo 2
Shanghai 2
Amsterdam 1
Ankara 1
Ardabil 1
Bristol 1
Brno 1
Böblingen 1
Chongqing 1
Foggia 1
Fuzhou 1
Hat Yai 1
Hefei 1
Heze 1
Indiana 1
Jacksonville 1
Jinan 1
Kilburn 1
Leawood 1
Mascalucia 1
Napoli 1
Norwalk 1
Nuremberg 1
Prescot 1
Qingdao 1
Quanzhou 1
Rome 1
Sofia 1
Taizhou 1
Taranto 1
Tianjin 1
Tiantai Chengguanzhen 1
Vilnius 1
Zibo 1
Zurich 1
Totale 613
Nome #
A Polygenic Risk Score of glutamatergic SNPs associated with schizophrenia predicts attentional behavior and related brain activity in healthy humans 131
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 112
TRAIL effect on osteoclast formation in physiological and pathological conditions 103
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 57
The genetic background and vitamin D supplementation can affect irisin levels in Prader–Willi syndrome 50
The effect of Irisin on bone cells in vivo and in vitro 49
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 42
FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective 40
Irisin and Secondary Osteoporosis in Humans 36
T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients 32
The novel role of PGC1α in bone metabolism 29
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 25
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 20
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 14
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 14
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis. 10
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 10
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 9
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 9
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 9
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 8
Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle 8
Totale 817
Categoria #
all - tutte 4.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020101 17 5 6 7 6 11 12 11 7 13 2 4
2020/2021135 3 2 8 4 2 1 20 11 36 5 26 17
2021/202298 1 5 0 3 5 13 2 6 17 7 16 23
2022/2023185 11 29 12 8 9 25 12 27 30 0 5 17
2023/2024158 13 23 7 10 7 36 13 3 2 9 15 20
2024/202571 71 0 0 0 0 0 0 0 0 0 0 0
Totale 817